ClinicalTrials.Veeva

Menu

B-lynch Transverse Compression Suture

A

Alexandria University

Status

Enrolling

Conditions

Blood Loss, Surgical

Treatments

Procedure: B-Lynch Transverse Compression Suture

Study type

Interventional

Funder types

Other

Identifiers

NCT06359886
FMASU MD 292/2022

Details and patient eligibility

About

Is B-Lynch transverse compression suture safe and effective in controlling excessive blood loss during conservative management of women with placenta previa?

Full description

To perform B-Lynch Transverse Compression Suture the investigators will use the suture material 1 Polyglactin 910 with a 70mm ½ circle needle mounted on a 90 cms suture. the investigators will use the needle blunt ended to puncture the uterus 3 cms above the upper margin of the incision posteriorly and behind the vascular bundle.

The needle is retrieved through the cavity of the uterus and pulled inferiorly with the suture material lying on the posterior wall of the uterine cavity. The needle then perforates the posterior wall of the uterus 1-3 cms below the inferior margin of the Caesarean incision and exists behind the vascular bundle of the same side of the uterus retrieved and runs on the surface of the lower segment below the incision margin parallel to it and taking a 1 cm bite of tissue for stabilization running to the other side.

After encircling the para-uterine vasculature, the needle then perforates the posterior side of the uterus behind the vascular bundle entering the uterine cavity 1-3 cm below the inferior margin of the Caesarean incision. The suture can lie freely on the posterior wall of the uterine cavity and exists 3 cms above the upper margin of the Caesarean incision. It exits posteriorly and behind the vascular bundle to meet the suture from the other side.

It is essential that the ureters are identified by palpation or visual observation after the bladder is displaced inferiorly and held by traction. Any observed bleeding should be dealt with in the usual way. At the end of the suture application and before tying the knots, the lower segment is compressed again transversely whilst the suture is held taut to ensure that bleeding has ceased by swabbing the vagina again.

A wide pore drain will be inserted in the Douglas pouch, and the abdominal wall will be repaired.

Enrollment

25 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Single gestation
  2. Elective CS for placenta preiva (diagnosed by transvaginal ultrasound).
  3. Muliparity (para 2 or more).

Exclusion criteria

  1. Morbidly adherent placenta: accrete, increta or percreta, diagnosed by abdominal and/or transvaginal ultrasound.

    • Ultrasonographic features of morbidly adherent placentas:

    • Loss of Retro-placental sonolucent zone.
    • Vascular lacunae.
    • Myometrial thinning.
    • Interruption of the bladder border.
  2. More than 3 previous C.S.

  3. Severely haemodynamic instablility needing immediate hysterectomy.

  4. Patients with the cardiac, hepatic, renal or thromboembolic disease

  5. Patients with coagulopathy:

    • Receiving anticoagulant therapy.
    • With thrombocytopenia or thrombasthenia.
    • Known coagulation factor defect.
  6. Distorted uterus as unicornuate, bicornuate, fibroid uterus and adenomyosis uteri.

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

25 participants in 1 patient group

B-Lynch Transverse Compression Suture
Experimental group
Description:
Transverse B-Lynch suture will be performed to these patients as a method of controlling postpartum heamorrhage in placenta previa patients
Treatment:
Procedure: B-Lynch Transverse Compression Suture

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed S Zeerban, Msc; Asmaa F Kassem, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems